Get 20% lifetime commission for referring investors to digrin.com
here.
aTyr Pharma, Inc. (LIFE) Financials
Stock symbol LIFE is outdated, potentially delisted? Maybe it is available on other exchange?
LIFE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2024 | 113.3 million | 29.0 million |
| Dec. 31, 2023 | 122.1 million | 31.6 million |
| Sept. 30, 2023 | 125.1 million | 26.9 million |
| June 30, 2023 | 132.7 million | 26.7 million |
LIFE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2024 | -22.4 million | 740000 |
| Dec. 31, 2023 | -11.1 million | 659000 |
| Sept. 30, 2023 | -10.1 million | 664000 |
| June 30, 2023 | -14.4 million | 658000 |
LIFE Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| March 31, 2024 | -15.5 million |
| Dec. 31, 2023 | -14.8 million |
| Sept. 30, 2023 | -11.3 million |
| June 30, 2023 | -12.3 million |
LIFE Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2024 | 84.5 million | 13.0 million | 13.0 million |
| Dec. 31, 2023 | 98.2 million | 13.8 million | 13.8 million |
| Sept. 30, 2023 | 105.6 million | 14.0 million | 15.2 million |
| June 30, 2023 | 108.6 million | 14.3 million | 15.4 million |
LIFE Shares Outstanding
LIFE Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2024 | 17000 | 13.4 million | 2.7 million | -770000 |
| Dec. 31, 2023 | 17000 | 12.8 million | 2.8 million | -407000 |
| Sept. 30, 2023 | 557000 | 10.3 million | 2.6 million | - |
| June 30, 2023 | 2.4 million | 9.8 million | 3.7 million | - |
LIFE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2024 | 235000 | 770000 |
| Dec. 31, 2023 | 4.3 million | 407000 |
| Sept. 30, 2023 | 353000 | 993000 |
| June 30, 2023 | - | 586000 |
LIFE Revenue by Segment
Graph available only for paid members. Upgrade to see it.
LIFE
Price: $1.90
52 week price:
Earnings Per Share: -0.88 USD
P/E Ratio: -1.77
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 171300
Ebitda: -10.7 millionMarket Capitalization: 131.1 million